ObsEva SA (OBSV)
(Delayed Data from NSDQ)
$13.89 USD
-0.12 (-0.86%)
Updated May 3, 2019 04:13 PM ET
After-Market: $13.76 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[OBSV]
Reports for Purchase
Showing records 101 - 120 ( 170 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
Long-Term data from Phase 2b Linzagolix for Endometriosis- Associated Pain
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
Long-Term Linzagolix Endometriosis Efficacy Data Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
6-Mo Infant Follow-up Data Validates Nolasiban?s Breakthrough Clinical Profile
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
Supplemental Infant Data Underscore Nolasiban Value Proposition; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
4Q and FY2018 Financial Results Reported; Multiple Near- and Mid-Term Clinical Catalysts; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Biomedical and Genetics
Q4 FY18; Several Key Data Readouts in 2019 - 2020; Recommend Buying on Weakness
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST - Adding SLM and Removing DHI and PFPT
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST - Adding DIN and removing TACO
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
Go/No-go Decision for OBE022/ Preterm Labor Anticipated in Q1
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L